205 related articles for article (PubMed ID: 30251219)
1. The Exosome: a New Player in Diabetic Cardiomyopathy.
Tao L; Shi J; Yang X; Yang L; Hua F
J Cardiovasc Transl Res; 2019 Feb; 12(1):62-67. PubMed ID: 30251219
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective Effects of Exosomes and Their Potential Therapeutic Use.
Ding S; Zhang J; Dai Q; Zhao M; Huang H; Xu Y; Zhong C
Adv Exp Med Biol; 2017; 998():163-177. PubMed ID: 28936739
[TBL] [Abstract][Full Text] [Related]
3. New Insights into the Role of Exosomes in the Heart After Myocardial Infarction.
Li N; Rochette L; Wu Y; Rosenblatt-Velin N
J Cardiovasc Transl Res; 2019 Feb; 12(1):18-27. PubMed ID: 30173401
[TBL] [Abstract][Full Text] [Related]
4. Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy.
Salem ESB; Fan GC
Adv Exp Med Biol; 2017; 998():113-138. PubMed ID: 28936736
[TBL] [Abstract][Full Text] [Related]
5. Exosomes in Cardiovascular Diseases and Treatment: Experimental and Clinical Aspects.
Wang J; Zhao C; Xiao J
J Cardiovasc Transl Res; 2019 Feb; 12(1):1-2. PubMed ID: 30617761
[No Abstract] [Full Text] [Related]
6. The Potential of Stem Cells and Stem Cell-Derived Exosomes in Treating Cardiovascular Diseases.
Ni J; Sun Y; Liu Z
J Cardiovasc Transl Res; 2019 Feb; 12(1):51-61. PubMed ID: 29525884
[TBL] [Abstract][Full Text] [Related]
7. Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases.
Song YH; Shao L; Zhang Y; Zhou J; Liu B; Pan X; Geng YJ; Yu XY; Li Y
Adv Exp Med Biol; 2017; 998():187-206. PubMed ID: 28936741
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease.
Suzuki E; Fujita D; Takahashi M; Oba S; Nishimatsu H
Adv Exp Med Biol; 2017; 998():179-185. PubMed ID: 28936740
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.
Zhang Z; Yang J; Yan W; Li Y; Shen Z; Asahara T
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811168
[TBL] [Abstract][Full Text] [Related]
10. The interplay of inflammation, exosomes and Ca
Sanganalmath SK; Dubey S; Veeranki S; Narisetty K; Krishnamurthy P
Cardiovasc Diabetol; 2023 Feb; 22(1):37. PubMed ID: 36804872
[TBL] [Abstract][Full Text] [Related]
11. Exosomal Mst1 transfer from cardiac microvascular endothelial cells to cardiomyocytes deteriorates diabetic cardiomyopathy.
Hu J; Wang S; Xiong Z; Cheng Z; Yang Z; Lin J; Wang T; Feng X; Gao E; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3639-3649. PubMed ID: 30251683
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease.
Radosinska J; Bartekova M
Adv Exp Med Biol; 2017; 998():221-235. PubMed ID: 28936743
[TBL] [Abstract][Full Text] [Related]
13. Exosomes: promising sacks for treating ischemic heart disease?
Chen GH; Xu J; Yang YJ
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H508-H523. PubMed ID: 28646026
[TBL] [Abstract][Full Text] [Related]
14. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair.
Mol EA; Goumans MJ; Sluijter JPG
Adv Exp Med Biol; 2017; 998():207-219. PubMed ID: 28936742
[TBL] [Abstract][Full Text] [Related]
16. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy.
Ahmad I; Hoda M
Pharmacol Res; 2020 Nov; 161():105112. PubMed ID: 32758636
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
[TBL] [Abstract][Full Text] [Related]
19. Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.
Nandi SS; Mishra PK
Adv Exp Med Biol; 2018; 1056():47-59. PubMed ID: 29754174
[TBL] [Abstract][Full Text] [Related]
20. Activation of the
Sun Y; Wang Q; Fang Y; Wu C; Lu G; Chen Z
Dis Model Mech; 2017 Oct; 10(10):1217-1227. PubMed ID: 28801532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
